TABLE 2.

Adjusted mean changes by treatment condition from baseline to 6 and 18 mo¹

Variable	Almond-enriched diet	Nut-free diet	P value2
Weight (kg)
6 mo	−5.5 ± 0.6	−7.4 ± 0.7	0.04
18 mo	−3.7 ± 1.0	−5.9 ± 1.0	0.12
Triglycerides (mg/dL)
6 mo	−12.1 ± 4.6	1.0 ± 4.6	0.048
18 mo	−4.1 ± 6.4	−10.3 ± 5.6	0.47
Total cholesterol (mg/dL)
6 mo	−8.7 ± 2.8	−0.1 ± 2.8	0.03
18 mo	3.7 ± 3.5	5.8 ± 3.1	0.64
VLDL cholesterol (mg/dL)
6 mo	−2.4 ± 1.5	1.4 ± 1.5	0.07
18 mo	2.3 ± 1.6	3.5 ± 1.4	0.58
LDL cholesterol (mg/dL)
6 mo	−5.4 ± 2.9	−0.2 ± 2.9	0.21
18 mo	−3.1 ± 2.7	−0.1 ± 2.5	0.41
HDL cholesterol (mg/dL)
6 mo	0.4 ± 1.1	−0.6 ± 1.1	0.52
18 mo	4.6 ± 1.7	2.3 ± 1.6	0.32
Total:HDL cholesterol
6 mo	−0.2 ± 0.1	0.04 ± 0.1	0.02
18 mo	−0.2 ± 0.1	−0.1 ± 0.1	0.52
Systolic blood pressure (mm Hg)
6 mo	−3.9 ± 1.6	−5.7 ± 1.7	0.44
18 mo	−3.2 ± 2.1	−3.6 ± 2.0	0.89
Diastolic blood pressure (mm Hg)
6 mo	−0.8 ± 0.9	−1.6 ± 1.0	0.56
18 mo	0.7 ± 1.1	−1.3 ± 1.0	0.19
Lean mass (kg)
6 mo	−1.8 ± 0.3	−2.5 ± 0.3	0.22
18 mo	−1.4 ± 0.4	−2.4 ± 0.4	0.09
Fat mass (kg)
6 mo	−3.7 ± 0.5	−5.0 ± 0.5	0.06
18 mo	−3.0 ± 0.8	−4.0 ± 0.8	0.39

¹All values are adjusted means ± SEs. None of the variables had a significant time-by-treatment interaction. A priori analyses were conducted at 6 and 18 mo.

²P values are for between-group differences based on linear mixed-effects models; baseline values of the outcome, time, treatment, and a time-by-treatment interaction were the principal explanatory variables.